- Member, Society of Biological Psychiatry (2018)
- Elected Member, American College of Neuropsychopharmacology (2019)
- Member, Schizophrenia International Research Society (2019)
- Distinguished Fellow of the American Psychiatric Association (2023)
- Member, Neural Basis of Psychopathology, Addictions and Sleep Disorders (NPAS) Study Section (2024)
Jennifer Coughlin, M.D.
- Communities Foundation of Texas, Inc. Chair in Brain Science
- Psychiatry
Biography
Jennifer Coughlin, M.D., is a Professor and Director of the Molecular Imaging in Psychiatry Program at UT Southwestern Medical Center. She holds a secondary appointment in the Peter O’Donnell Jr. Brain Institute. Dr. Coughlin also has an adjunct appointment as Professor of Psychiatry and Behavioral Sciences at Johns Hopkins University.
After growing up in Baltimore, Dr. Coughlin received her M.D. from the University of Maryland School of Medicine. She then completed her internship and psychiatric residency training, followed by a clinical research fellowship in molecular psychiatry at the Johns Hopkins University in Baltimore, Maryland,
Before joining UT Southwestern Medical Center in 2024, Dr. Coughlin directed the Johns Hopkins Young Adult Affective Disorders Inpatient Service and the Young Adult Affective Disorders Consultation Clinic.
Dr. Coughlin focuses her research on molecular neuroimaging techniques, particularly the use of novel radiotracers with positron emission tomography (PET). Her team aims to inform the molecular understanding of neuropsychiatric conditions, and identify novel, precision therapies guided by imaging results. Recent research has focused on the contribution of the neuroimmune response to neurologic and psychiatric conditions spanning studies of repeated traumatic brain injury, psychosis, treatment-resistant mood disorders, Alzheimer’s disease, and healthy aging. Dr. Coughlin’s work has uncovered evidence of past brain injury in former collision sport athletes and is guiding studies of how the brain’s immune response may be modulated to promote repair. New radiotracers for use with PET are clarifying the immune contribution to treatment-resistant Major Depressive Disorder and to psychotic conditions.
Dr. Coughlin’s commitment to addressing unmet medical needs is evidenced by her continued clinical commitments to patient care and membership in initiatives to grow a future workforce of clinician scientists. She recently joined the UTSW Multispecialty Psychiatry Clinic and focuses on initial evaluations of young adults with suspected affective illness. She also participates in the UTSW Clinical Scholars Program Selection Committee.
During her spare time, Dr. Coughlin enjoys the arts, outdoor activities, and cheering for her children at swim meets.
Professional Associations & Affiliations
Honors & Awards
- Invited Participant 2009, NIH Brain Camp
- Invited Participant 2010, Career Development Institute for Psychiatry Program
- Recipient NIH Loan Repayment Program 2011
- Young Investigator Award 2013, Brain & Behavior Research Foundation (formerly NARSAD)
- Invited Participant 2014, 2014 Brain & Behavior Research Foundation National Awards Dinner
- Best Manuscript by an Early Career Psychiatrist 2016 2016, Maryland Psychiatric Society
- Johns Hopkins Discovery Fund Innovation Award 2016
- The Ryan Licht Sang Bipolar Foundation Research Award 2017
- Johns Hopkins Doris Duke Foundation Early Clinician Investigator Award 2017
- Selected Participant 2017, 2017 Leadership Program for Women Faculty, Johns Hopkins Medicine
- Johns Hopkins University Catalyst Award 2018
- Gifford Foundation Rising Star Schizophrenia Research Award 2019, One Mind
- Defeating Depression Award 2020, The Hope for Depression Research Foundation
- Selected Participant 2021, 2021-2022 Leadership Development Program, Johns Hopkins Medicine
- Distinguished Fellow of the American Psychiatric Association 2023
- (EJNMMI) Research Best Paper 2023 2023, European Journal of Nuclear Medicine and Medical Imaging
- Invited Participant 2023, Rising Star Leadership Program, One Mind Foundation
- Selected Participant 2023-2024, Leading Transformation for Value-based Health Care: Executive Education Program, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD
Books & Publications
-
Publications
-
Hippocampal Availability of the α7 Nicotinic Acetylcholine Receptor in Recent-Onset Psychosis
Wong NR, Rubin LH, Harrington CK, Jenkins KR, Shinehouse LK, Yoon M, Kilgore JJ, Soule AR, Lesniak WG, Rowe SP, Horti AG, Kamath V, Dannals RF, Du Y, Pomper MG, Coughlin JM 2024 -
Imaging brain injury in former National Football League players
Rubin LH, Du Y, Sweeney SE, et al. JAMA Network Open 2023 -
[18F]FNDP PET Neuroimaging Test-Retest Repeatability and Whole Body Dosimetry in Humans
Du Y, Coughlin JM, Amindarolzarbi A, Sweeney SE, Harrington CK, Brosnan MK, Zandi A, Shinehouse LK, Reyes Sanchez AN, Abdallah R, Holt DP, Fan H, Lesniak WG, Nandi A, Rowe SP, Solnes LB, Dannals RF, Horti AG, Lodge MA, Pomper MG EJNMMI 2023 -
Pilot imaging of the colony stimulating factor 1 receptor in the brains of virally-suppressed individuals with HIV
Rubin LH, Du Y, Sweeney SE, OToole R, Harrington CK, Jenkins K, Lesniak WG, Veenhuis RT, Dastgheyb R, Severson J, Fan H, Holt DP, Hall AW, Dannals RF, Horti AG, Pomper MG, Coughlin JM AIDS 2023 -
First in Human Imaging Using [11C]MDTC, A Radiotracer Targeting the Cannabinoid Receptor Type 2
Du Y, Coughlin JM, Brosnan MK, Chen A, Shinehouse LK, Abdallah R, Lodge MA, Mathews WB, Liu C, Wu Y, Minn I, Finley P, Hall AW, Lesniak WG, Dannals RF, Horti AG, Pomper MG EJNMMI 2023 -
First-in-human use of [11C]CPPC with positron emission tomography for imaging the macrophage colony stimulating factor 1 receptor
Coughlin JM, Du Y, Lesniak WG, Harrington CK, Brosnan MK, OToole R, Zandi A, Sweeney SE, Abdallah R, Wu Y, Holt DP, Hall AW, Dannals RF, Solnes L, Horti AG, Pomper MG EJNMMI 2022 -
First-in-human neuroimaging of soluble epoxide hydrolase using [18F]FNDP PET
Coughlin JM, Slania S, Du Y, Shinehouse LK, Brosnan MK, Behnam Azad B, Holt DP, Fan H, Lesniak WG, Minn I, Rowe SP, Dannals RF, Horti AG, Pomper MG EJNMMI 2021 -
A multimodal approach to studying the relationship between peripheral glutathione, brain glutamate, and cognition in health and in schizophrenia
Coughlin JM, Yang K, Marsman A, Pradhan S, Wang M, Ward RE, Bonekamp S, Ambinder EB, Higgs CP, Kim PK, Edwards JA, Varvaris M, Wang H, Posporelis S, Ma S, Tsujimura T, Edden RAE, Pomper MG, Sedlak T, Fournier M, Schretlen DJ, Cascella NG, Barker PB, Sawa A Mol Psychiatry 2021 -
Assessing Brain Metabolism With 7T Proton Magnetic Resonance Spectroscopy in Patients With First-Episode Psychosis
Wang AM, Pradhan S, Coughlin JM, Trivedi A, DuBois SL, Crawford JL, Sedlak TW, Nucifora FC Jr, Nestadt G, Nucifora LG, Schretlen DJ, Sawa A, Barker PB JAMA Psychiatry 2019 -
High availability of the α7 nicotinic acetylcholine receptor in brains of individuals with mild cognitive impairment: a pilot study using [18F]ASEM PET
Coughlin JM, Rubin LH, Du Y, Rowe SP, Crawford JL, Rosenthal HB, Frey SM, Marshall ES, Shinehouse LK, Chen A, Speck CL, Wang Y, Lesniak WG, Minn I, Bakker A, Kamath V, Smith GS, Albert MS, Behnam Azad B, Dannals RF, Horti A, Wong DF, Pomper MG J Nucl Med 2019 -
The availability of the α7 nicotinic acetylcholine receptor in recent-onset psychosis: a study using [18F]ASEM PET
Coughlin J, Du Y, Crawford JL, Rubin LH, Behnam Azad B, Lesniak WG, Horti AG, Schretlen DJ, Sawa A, Pomper MG J Nucl Med 2019 -
18F-XTRA PET for enhanced imaging of the extrathalamic α4β2 nicotinic acetylcholine receptor
Coughlin JM, Slania S, Du Y, Rosenthal HB, Lesniak WG, Minn I, Smith G, Dannals RF, Kuwabara H, Wong DF, Wang Y, Horti A, Pomper MG J Nucl Med 2018 -
Microglial activation is inversely associated with cognition in individuals living with HIV on effective antiretroviral therapy
Rubin LH, Sacktor N, Creighton J, Du Y, Endres CJ, Pomper MG, Coughlin JM AIDS 2018 -
Translational evaluation of translocator protein as a marker of neuroinflammation in schizophrenia
Notter T, Coughlin JM, Gschwind T, Weber Stadlbauer U, Wang Y, Kassiou M, Vernon AC, Benke D, Pomper MG Mol Psychiatry 2018 -
The Distribution of the Alpha7 Nicotinic Acetylcholine Receptor in Healthy Aging: An In Vivo Positron Emission Tomography Study with [18F]ASEM
Coughlin JM, Du Y, Rosenthal HB, Slania S, Koo SM, Park A, Solomon G, Vranesic M, Antonsdottir I, Speck CL, Rootes Murdy K, Lerner A, Rowe SP, Wang Y, Lesniak WG, Minn I, Bakker A, Smith G, Dannals RF, Kuwabara H, Horti A, Wong DF, Pomper MG Neuroimage 2018 -
Imaging of glial cell activation and white matter integrity in brains of active and recently retired National Football League players
Coughlin, JM , Wang, Y, Minn I, Bienko N, Ambinder EB, Xu X, Peters ME, Dougherty JW, Vranesic M, Koo SM, Ahn H, Lee M, Cottrell C, Sair HI, Sawa A, Munro CA, Nowinski CJ, Dannals RF, Lyketsos CG, Kassiou M, Smith G, Caffo B, Mori S, Guilarte TR, Pomper MG JAMA Neurology 2017 -
In vivo markers of inflammatory response in recent onset schizophrenia: A combined study using [11C]DPA-713 PET and analysis of CSF and plasma
Coughlin JM, Wang Y, Ambinder E, Ward R, Minn I, Vranesic M, Kim PK, Ford C, Higgs C, Hayes L, Schretlen D, Dannals RF, Kassiou M, Sawa A, Pomper MG Translational Psychiatry 2016
-
Hippocampal Availability of the α7 Nicotinic Acetylcholine Receptor in Recent-Onset Psychosis
Research
- Positron Emission Tomography
- Magnetic Resonance Spectroscopy
- Inflammation
- Bipolar Disorder
- Treatment-resistant Major Depressive Disorder
- Psychosis (Schizophrenia, Schizoaffective Disorder)
- Traumatic Brain Injury